NEXT Oncology - Austin — Austin, Texas

NEXT Oncology - Austin is a clinical research site located in Austin, Texas, United States 78758.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

NEXT Oncology - Austin has participated in 8 clinical trials with 5 currently active.

Therapeutic areas: Oncology, MEK Mutation, RAF Gene Mutation.

Sponsors: Nested Therapeutics, Inc, InSilico Medicine Hong Kong Limited, Nitto BioPharma, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology - Austin?

NEXT Oncology - Austin has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology - Austin conducted?

NEXT Oncology - Austin has 8 clinical trials on record, with 5 currently active. Their work covers Oncology, MEK Mutation, RAF Gene Mutation.

Is NEXT Oncology - Austin accredited by Crixeo Health?

Yes — NEXT Oncology - Austin holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NEXT Oncology - Austin?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.